2025 APA Scientific Conference

 
 50% of survey complete.
Please click "Next" if you did not attend this session

Question Title

* The session met the stated learning objectives:

  Strongly disagree Disagree Somewhat disagree Neither agree or disagree Somewhat agree Agree Strongly agree
Review the growing evidence for use of ketamine in treatment resistant depression;
Discuss the abuse liability of ketamine;
Analyze trends in ketamine prescribing in Alberta between January 1, 2021, to June 30, 2024; and
Consider future directions for research in the abuse liability of ketamine.

Question Title

* Please rate the following on a scale of 1 to 5
(1 - strongly disagree and 5 - strongly agree):

  Strongly disagree Disagree Somewhat disagree Neither agree or disagree Somewhat agree Agree Strongly agree
The session was educationally relevant.
The presenter was educationally effective.
The session provided interactive opportunities.
The session provided opportunities to identify and/or reflect on what was learned and its potential impact on my practice

Question Title

* Please rate the following on a scale of 1 to 5
(1 - strongly disagree and 5 - strongly agree):

  Strongly disagree Disagree Somewhat disagree Neither agree or disagree Somewhat agree Agree Strongly agree
The session and presenter did NOT have commercial or other inappropriate bias.

Question Title

* Please provide any other comments you would like to share:

T